President of Pasteur Institute of Iran Alireza Biglari said that Pasteurcovac Vaccine, jointly developed by Iran and Cuba, has proved to be 100% effective against Omicron variant of the COVID-19.
The CEO of the third phase of clinical trial of Iranian COVID-19 vaccine PastoCovac said that the third dose of the vaccine, named PastoCovac Plus, was authorized to be used as the booster dose for any other coronavirus vaccine.